North America Empty Capsules Market Report

North America Empty Capsules Market Size

The empty capsules market size in North America was valued at USD 687.24 million in 2025. The North American market size is further expected to reach USD 1,142.58 million by 2034 from USD 727.17 million in 2026, growing at a compound annual growth rate (CAGR) of 5.81% during the forecast period.

The empty capsules are the manufacturing and distribution of gelatin based and vegetarian shell alternatives used as primary dosage forms for pharmaceuticals nutraceuticals and dietary supplements, across the United States and Canada. As per the studies, over 60% of all oral solid dosage forms produced in North America utilize capsule technology due to its versatility in accommodating powders liquids and semi solids. The Food and Drug Administration mandates strict Good Manufacturing Practices for capsule production ensuring purity and consistency which directly influences supply chain dynamics. The definition extends beyond mere container production to include advanced functional coatings and modified release technologies that address specific therapeutic needs. Regulatory frameworks under the Dietary Supplement Health and Education Act further shape product specifications requiring transparent labeling of capsule materials such as bovine porcine or plant derived sources.

MARKET DRIVERS

Surging Demand for Nutraceuticals and Dietary Supplements

The exponential growth in consumer health consciousness has unprecedented demand for dietary supplements, which is solely fuelling the growth of the North America empty capsules market. Adults in the United States reported using dietary supplements in 2023, representing a steady increase from previous years driven by preventive healthcare trends. This widespread adoption necessitates robust manufacturing capacity for both gelatin and vegetarian capsules to accommodate diverse formulation requirements including vitamins minerals and herbal extracts. The shift toward personalized nutrition further amplifies this driver as consumers seek customized blends that require flexible encapsulation solutions. Manufacturers respond by expanding production lines capable of handling small batch runs with high precision thereby supporting niche brands entering the market.

Preference for Vegetarian and Vegan Friendly Formulations

Changing dietary preferences and ethical considerations have significantly accelerated the transition from traditional gelatin to plant based empty capsules that is also elevating the growth of the North America empty capsules market. As per the study, retail sales of plant based alternatives reached 8 billion dollars in 2023, reflecting a 9% annual growth rate that extends into pharmaceutical excipients and delivery systems. This cultural shift compels pharmaceutical and supplement manufacturers to reformulate products using hydroxypropyl methylcellulose or pullulan-based capsules to appeal to vegan and vegetarian demographics. Regulatory bodies also support this trend by requiring clear labeling of animal derived ingredients, which prompts brands to switch to plant based options to avoid alienating conscious consumers. The technical advancements in vegetable capsule manufacturing now offer comparable stability and dissolution profiles to gelatin enabling seamless substitution without compromising efficacy.

MARKET RESTRAINTS

Volatility in Raw Material Prices for Gelatin and Polymers

The fluctuating costs of key raw materials are affecting profit margins and pricing stability that is restricting the growth of the North America empty capsules market. This cost escalation forces manufacturers to either absorb losses or pass increases to customers risking contract cancellations in price sensitive segments like generic pharmaceuticals. Such unpredictability complicates long term planning and budgeting for both suppliers and end users who operate on thin margins. The dependence on agricultural outputs makes the industry vulnerable to weather conditions disease outbreaks and trade policies that impact raw material availability. Manufacturers struggle to maintain consistent quality while managing cost pressures leading to potential compromises in production efficiency.

Stringent Regulatory Compliance and Quality Control Standards

The rigorous regulatory requirements imposed by health authorities create substantial operational burdens and entry barriers for empty capsule manufacturers that is also degrading the growth of the North America empty capsule market. As per the Food and Drug Administration, guidelines updated in 2024, manufacturers must adhere to current Good Manufacturing Practices, which include extensive testing for microbial contamination heavy metals and residual solvents. Compliance with these standards requires significant investment in laboratory infrastructure personnel training and documentation systems increasing overall production costs. Failure to meet these stringent criteria can result in warning letters import bans or product recalls damaging brand reputation and causing financial losses. The complexity of navigating different regulatory frameworks across the United States Canada and Mexico further complicates operations for multinational suppliers. Small and medium enterprises often lack resources to maintain continuous compliance limiting their market participation.

MARKET OPPORTUNITIES

Expansion of Modified Release and Functional Capsule Technologies

The innovation in capsule design for manufacturers to differentiate products through advanced functional features such as enteric coating and controlled release mechanisms is ascribed to fuel new opportunities for the expansion of the North America empty capsules market. Empty capsule producers can capitalize on this trend by developing shells with specialized polymer coatings that protect active ingredients from stomach acid or enable targeted intestinal release. These advanced capsules command higher margins due to technical complexity and value-added benefits for pharmaceutical clients seeking patent extension strategies. Collaboration with drug developers early in formulation stages allows capsule manufacturers to co create tailored solutions addressing specific pharmacokinetic challenges. This technological evolution transforms empty capsules from passive containers into active components of drug delivery enhancing therapeutic outcomes and opening new revenue streams in specialty pharmaceuticals and complex generic sector.

Growth in Contract Manufacturing and Private Label Services

The rise of contract manufacturing organizations and private label supplement brands to expand their customer base beyond traditional pharmaceutical giants that is also to enhance the growth of the North America empty capsules market. These emerging companies often lack in house production capabilities relying on external partners for encapsulation services creating demand for flexible and scalable capsule supply chains. Empty capsule manufacturers can strengthen relationships with these contract processors by offering just in time delivery custom branding options and small minimum order quantities. This strategy enables penetration into fragmented market segments where agility and customization are valued over bulk pricing.

MARKET CHALLENGES

Supply Chain Disruptions and Geopolitical Instability

Global supply chain vulnerabilities continue to challenge the consistent availability of raw materials are also to decline the growth of the North America empty capsules market. Manufacturing supply chain pressures remained elevated in 2023 with lead times for imported polymers extending by 3 weeks on average due to port congestion and logistical hurdles. This instability affects manufacturers reliant on international sources for gelatin and plant-based polymers causing production delays and inventory shortages. Geopolitical tensions and trade restrictions further exacerbate these issues by limiting access to key suppliers in Asia and Europe. Manufacturers face difficult decisions regarding inventory buildup which ties up capital versus just in time procurement, which risks stockouts. The lack of transparency in multi-tier supply chains makes it challenging to predict and mitigate risks effectively. This operational uncertainty undermines customer confidence and forces companies to diversify sourcing strategies often at higher costs.

Competition from Alternative Dosage Forms

The emergence of alternative oral dosage forms is also to impede the growth of the North America empty capsules market. As per the study, global new product database launches of gummy supplements in North America increased by 25% in 2023 appealing to consumers seeking enjoyable and convenient consumption experiences. This trend particularly affects the nutraceutical sector where taste and texture play crucial roles in purchase decisions potentially reducing demand for traditional capsule formats. Pharmaceutical companies also explore tablet technologies with improved disintegration profiles that offer cost advantages over encapsulation. Empty capsule manufacturers must innovate to maintain relevance by highlighting benefits such as faster dissolution and absence of binders found in tablets.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Product Type Insights

The gelatin capsules segment was accounted in holding 32.1% of the North America Empty Capsules Market share in 2025 due to their superior mechanical properties cost effectiveness and widespread acceptance in pharmaceutical manufacturing. The entrenched production infrastructure for gelatin capsules provides significant economic advantages that sustain their market leadership across North America. This domestic availability reduces dependency on imports and mitigates logistical risks associated with global supply chains. The mature technology allows for high speed automated filling processes which minimize operational expenses for large scale pharmaceutical producers. Economies of scale achieved by major gelatin suppliers enable competitive pricing structures that are difficult for newer non gelatin materials to match. This cost efficiency is particularly crucial for high volume therapeutic areas such as antibiotics and pain management where margin pressures are intense.

The non-gelatin capsules segment is likely to grow at a fastest CAGR of 7.5% throughout the forecast period. The demographic shift toward plant based lifestyles is a primary catalyst accelerating the adoption of non-gelatin capsules made from hydroxypropyl methylcellulose or pullulan. According to the study, the number of consumers identifying as vegan or vegetarian in North America grew by 25% between 2020 and 2024, creating a substantial market for animal free pharmaceutical excipients. This cultural trend extends beyond diet into healthcare choices where patients actively seek products aligned with their ethical values. Data from the Vegan Society indicates that 60% of vegan consumers check ingredient labels for animal derived components before purchasing supplements or medications prompting brands to reformulate using plant based capsules. Pharmaceutical companies respond to this demand to avoid alienating a growing consumer base and to enhance brand image as socially responsible entities. The transparency required by modern consumers drives innovation in clear labeling and certification processes for non gelatin products.

By Therapeutic Application Insights

The dietary supplements and vitamins segment held a significant share of the North America Empty Capsules Market in 2025. The strong emphasis on preventive health among North American consumers fuels robust demand for vitamin and mineral supplements packaged in empty capsules. This high penetration rate creates sustained volume demand for capsule shells capable of holding powders oils and herbal extracts. Consumers perceive capsules as more natural and easier to digest compared to compressed tablets which often contain binders and fillers. The ability to customize capsule colors and sizes allows brands to create distinct visual identities enhancing shelf appeal in retail environments. This consumer preference drives manufacturers to prioritize capsule production lines for supplement clients ensuring consistent supply to meet seasonal spikes in demand particularly during winter months, when immune support products see increased sales.

The anti-inflammatory drugs segment is likely to witness a fastest CAGR of 6.8% during the forecast period with the aging population and rising prevalence of chronic inflammatory conditions. The demographic shift toward an older population in North America, significantly increases the incidence of chronic inflammatory diseases such as arthritis requiring long term medication management. This growing patient pool drives consistent demand for anti-inflammatory medications including nonsteroidal anti-inflammatory drugs which are frequently formulated in capsules to minimize gastric irritation. Pharmaceutical companies respond by developing extended release capsule formulations that provide sustained pain relief throughout the day improving quality of life for patients.

By End User Insights

The pharmaceutical industry segment was the largest by holding 34.2% of the North America Empty Capsules Market share in 2025 due to the extensive use of capsules in prescription and over the counter drug manufacturing. The sheer volume of prescription drugs produced in North America ensures dominant demand for empty capsules from the pharmaceutical sector. This massive scale requires reliable and high-capacity capsule suppliers capable of meeting strict quality and delivery standards. The patent cliff for many blockbuster drugs has accelerated generic competition driving manufacturers to optimize production costs through efficient capsule usage. Regulatory requirements for consistent drug content and dissolution performance favor capsule technologies that offer precise filling accuracy. The established validation protocols for capsule filling lines reduce time to market for new generic entries.

The nutraceutical industry segment is projected to expand at a CAGR of 8.2% from 2026 to 2034 with the consumer demand for personalized wellness solutions. The emergence of personalized nutrition platforms and direct to consumer wellness brands is reshaping the nutraceutical landscape and driving demand for flexible capsule solutions. These brands often require small batch production runs with customized ingredient blends, which are best served by empty capsule formats. The agility of capsule production allows these brands to rapidly iterate formulations based on customer feedback and emerging health trends. Consumers value the transparency and purity associated with capsule delivered supplements preferring them over processed tablets. This preference drives nutraceutical companies to prioritize capsule packaging in their product lines.

REGIONAL ANALYSIS

The United States Empty Capsules Market Analysis

The United States was the top performer in the North America Empty Capsules Market by accounting for 85.3% of share in 2025 with its massive pharmaceutical and supplement industries. According to the Food and Drug Administration, the United States approves approximately 40 new molecular entities annually many of which utilize capsule formulations for initial commercialization. This robust pipeline ensures continuous demand for high quality empty capsules from both innovative and generic drug manufacturers. The presence of major pharmaceutical hubs in states like New Jersey California and North Carolina facilitates efficient supply chain logistics for capsule distributors. Regulatory frameworks enforced by the FDA ensure high standards for excipient quality fostering trust in domestic suppliers. The strong intellectual property protection environment encourages investment in novel capsule technologies such as modified release and targeted delivery systems. High healthcare expenditure and insurance coverage for prescription drugs further support market growth.

Canada Empty Capsules Market Analysis

Canada empty capsules market was second by holding 10.2% of share in 2025 with the strong regulatory alignment with international standards and increasing focus on natural health products. As per Health Canada, the approval process for natural health products including supplements has streamlined in recent years leading to a 15% increase in new product notifications in 2023. This regulatory efficiency encourages domestic and international brands to launch capsule based supplements in the Canadian market. The growing popularity of vegan and organic products in Canada drives demand for non gelatin capsule alternatives aligning with consumer values. Major pharmaceutical companies maintain manufacturing facilities in Ontario and Quebec ensuring local supply of empty capsules for prescription drugs.

COMPETITIVE LANDSCAPE

The competitive landscape of the North America Empty Capsules Market is characterized by intense rivalry among established multinational corporations and specialized regional manufacturers striving for technological superiority. Major participants continuously invest in research and development to introduce innovative formulations that address growing concerns regarding raw material sourcing and environmental impact. This drive for innovation results in frequent product launches featuring enhanced stability profiles and tailored dissolution characteristics for specific drug compounds. Companies also compete through strategic partnerships and vertical integration aiming to secure raw material supplies and expand their service offerings. Digital transformation plays a crucial role as firms integrate advanced quality control systems and data analytics tools to provide personalized recommendations and improve operational efficiency. Regulatory compliance remains a significant differentiator with companies navigating complex approval processes to gain first mover advantages in new therapeutic categories. Price competition is moderate due to high barriers to entry and emphasis on quality over cost. Brand reputation and technical support significantly influence purchasing decisions creating loyalty among professional users.

KEY MARKET PLAYERS

Some of the companies that are playing a dominating role in the North America Empty Capsules Market include

• Capsugel
• ACG Worldwide
• Suheung Co. Ltd.
• Bright Pharmacaps Inc.
• CapsCanada Corporation
• Medi-Caps Ltd.
• Qualicaps
• Roxlor, LLC
• Snail Pharma Industry Co. Ltd.
• Sunil Healthcare Limited

Top Players in the North America Empty Capsules Market

Capsugel

 Capsugel stands as a premier manufacturer of empty capsules with extensive production facilities across North America serving pharmaceutical and nutraceutical clients. The company specializes in both gelatin and vegetarian capsule options offering customized solutions for complex drug formulations. Recent initiatives include expanding its manufacturing capacity in Kentucky to meet rising demand for high quality excipients. Capsugel actively invests in research and development to improve capsule dissolution profiles and stability under varying humidity conditions. Their strategic focus on sustainability involves implementing eco friendly manufacturing processes that reduce water and energy consumption. This commitment to innovation and customer service solidifies their reputation as a trusted partner in the oral dosage form industry.

ACG Associated Capsules

ACG Associated Capsules demonstrates strong market presence through its comprehensive portfolio of empty hard gelatin and HPMC capsules designed for diverse therapeutic applications. The company emphasizes vertical integration by controlling raw material sourcing to ensure consistent quality and supply reliability. Recent actions involve launching advanced automation technologies in their North American facilities to enhance production efficiency and reduce lead times. They have strengthened distribution networks by partnering with local logistics providers ensuring timely delivery to pharmaceutical manufacturers. Investment in digital quality control systems allows real time monitoring of production parameters maintaining strict compliance with regulatory standards. Their agile approach to market dynamics enables rapid response to emerging trends such as demand for vegan friendly options.

Lonza Group

Lonza Group maintains a prominent position in the North America Empty Capsules Market by leveraging global expertise and local manufacturing capabilities to serve key pharmaceutical hubs. The company focuses on high performance capsule solutions that support modified release and targeted delivery technologies. Recent developments include upgrading their production lines in New Jersey to accommodate increased demand for specialized vegetarian capsules. They actively engage in collaborative projects with biotech firms to develop novel encapsulation methods for sensitive biological molecules. Strategic alliances with contract manufacturing organizations facilitate seamless integration of capsule supply into broader drug production workflows. Their dedication to scientific excellence and operational efficiency ensures sustained growth and reinforces their status as a leader in advanced drug delivery systems throughout the region.

Top Strategies Used by Key Market Participants

Key players in the North America Empty Capsules Market primarily employ product innovation and strategic capacity expansion to maintain competitive advantage. Companies invest heavily in research and development to create novel polymer blends that overcome existing stability challenges while meeting strict regulatory safety standards. This focus on scientific advancement allows them to differentiate offerings in a crowded marketplace. Simultaneously firms establish collaborations with pharmaceutical and nutraceutical manufacturers to enhance distribution channels and improve client engagement. These alliances facilitate direct technical support and streamline supply chain processes increasing adoption rates. Additionally, manufacturers prioritize sustainability by developing eco-friendly production methods and biodegradable packaging materials aligning with regional environmental expectations. Such multifaceted strategies enable companies to address evolving market demands effectively while strengthening brand loyalty among professional and industrial consumers across North American nations.

MARKET SEGMENTATION

This research report on the North America Empty Capsules Market has been segmented and sub-segmented into the following categories.

By Product

• Gelatin Capsules
• Non-Gelatin Capsules

By Therapeutic Application

• Antibiotic and Antibacterial Drugs
• Antacid and Antiflatulent Preparations
• Anti-Anemic Preparations
• Anti-Inflammatory Drugs
• Cardiovascular Therapy Drugs
• Dietary Supplements and Vitamins
• Cough and Cold Preparations
• Other Therapeutic Applications

By End User

• Pharmaceutical Industry
• Cosmetics Industry
• Nutraceutical Industry
• Research Laboratories

By Country

• The U.S.
• Canada
• Rest of North America